期刊文献+

甲状腺功能亢进与白细胞减少关系的临床分析 被引量:3

下载PDF
导出
摘要 目的:探讨甲状腺功能亢进症(甲亢)患者白细胞减少的发生率、临床特点及关系。方法:对168例甲亢患者治疗前后白细胞数量与血清甲状腺激素水平的进行检测,并分析相关因素。结果:治疗前18.04%甲亢患者白细胞总数与中性粒细胞均减少,治疗后甲状腺激素水平与白细胞数量均有增加,与治疗前比较,有统计学意义(P<0.05)。结论:甲亢常致白细胞减少,与甲亢患者体内产生了针对白细胞的抗体、甲状腺素抑制骨髓正常的造血功能、甲状腺激素增多和抗甲状腺药物等因素有关,具体原因有利于进一步探索。
作者 朱柏乐
出处 《医学信息(中旬刊)》 2010年第5期1076-1077,共2页 Medical Information Operations Sciences Fascicule
  • 相关文献

参考文献6

二级参考文献22

  • 1何清华,陈德才,卢春燕,魏松全,田浩明.甲亢合并白细胞减少的临床分析[J].四川医学,2005,26(6):634-635. 被引量:11
  • 2白耀.甲状腺病学-基础与临床[M].北京:科学技术文献出版社,2004.388.
  • 3Weitzman SA,Stoesel TP,Harmon DC,et al.Antineutrophil autoantibodies in Graves'disease,Implications of thyropin binding to neutrophils [J]. J Clin Invest,1985,75:119-123.
  • 4Gutty MM,Goeken NE,Bruno CP.Granulocytotoxic antibodies in a patient with propyhhiouracil-induced agranulocytosis[J].Arch Intern Meal, 1984,144:1687-1688.
  • 5Tarmai H,Sodo T,Kimura A,et al.Association between the DRBI * 08032 histocompatibility antigen and methimazole-induced ageanulocytosis in Japanese patients with Graves disease[J].Atom Intern Med, 1996,124:490-494.
  • 6Davies TF, Larsen PR. Thyrotixicosis// Larsen PR, Kronenberg HM, Melmed S. Wlilliams textbook of endocrinology. 10th ed. Philadelphia: Saunders, 2002: 374-424.
  • 7Chiovato L, Babesino G, Pinchera A. Graves disease//DeGroot LJ, Jameson JL. Endocrinology. 4th ed. Philadelphia: Saunders, 2001 : 1422-1449.
  • 8Greenspan FS. The thyroid gland//Greenspan FS, Gardner DG. Basic and clinical endocrinology. New York: Lange /McGraw- Hill, 2001: 201-272.
  • 9Fisher DA. Disorders of the thyroid in the newborn and infant// Sperling MA. Pediatric endocrinology. 2nd ed. Philadelphia: Sannders, 2002 : 161-186.
  • 10Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med, 2000, 160:1573-1575.

共引文献861

同被引文献25

  • 1李丽琴,杨星,洪军,刘晶.^(131)碘有效安全治疗毒性弥漫性甲状腺肿伴白细胞、血小板减少[J].临床误诊误治,2004,17(9):616-617. 被引量:5
  • 2Tsuboi K,Ueshiba H,Shimojo M,et al.The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves'disease.Endocrine J,2007,54:39-43.
  • 3David S,Cooper MD.Antithyroid drugs.New Engl J Med,2005,352:915-917.
  • 4滕卫平 曾正陪 李光伟 等.中国甲状腺疾病诊治指南[J].中华内科杂志,2007,:876-876.
  • 5Gianoukakis AG,Leigh MJ,Richards P,et al.Characterization of the anaemia associated with Graves' disease.Clin Endocrinol(Oxf),2009,70:781-787.
  • 6Simchen C,Lihmann I,Sittig D,et al.Expression and regulation of regulated on activation,normal T cells expressed and secreted in thyroid tissue of patients with Graves' disease and thyroid autonomy and in thyroid derived cell populations.J Clin Endocrinol Metab,2000,85:4758-4764.
  • 7Laurberg P,Bulow Pedersen I,Knudsen N,et al.Environ-mental iodine intake affects the type of nonmalignant thyroid disease.Thyroid,2001,11:457-469.
  • 8Tamai H,Sudo T,Kimura A,et al.Association between the DR.B1 ×08032 Histocompatiblity.Antigen and methimazol-induced agranulocytosis in Japanese patients with Graves Disease.Amn Intern Med,1996,124:490-494.
  • 9Eheman CR,Garbe P,Tuttle RM.Autoimmune thyroid disease associated with environmental thyroidal irradiation.Thyroid,2003,13:453-464.
  • 10伍军伟,凌俊宏,龙健忠,王福诩.Graves’病合并粒细胞减少或缺乏研究进展[J].中国现代医药杂志,2009,11(2):139-140. 被引量:11

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部